adiporon

Adiponectin receptor agonists such as AdipoRon have attracted interest as potential therapies for obesity, diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and a panoply of other conditions. Reference standards of Adiporon API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

No Data Found